Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition

por Salem, Mostafa E., Mahrous, Esraa M., Ragab, Eman A., Nafie, Mohamed S., Dawood, Kamal M.
Publicado 2023

Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine) Derivatives as EGFR/CDK-2 Target Inhibitors

por Salem, Mostafa E., Mahrous, Esraa M., Ragab, Eman A., Nafie, Mohamed S., Dawood, Kamal M.
Publicado 2023